Freedom Investment Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,604
| Closed | -$257K | – | 745 |
|
|
2025
Q1 | $257K | Sell |
10,604
-2,106
| -17% | -$51.1K | 0.02% | 643 |
|
|
2024
Q4 | $265K | Sell |
12,710
-3,200
| -20% | -$66.8K | 0.02% | 638 |
|
|
2024
Q3 | $316K | Sell |
15,910
-3,223
| -17% | -$64.1K | 0.03% | 582 |
|
|
2024
Q2 | $296K | Buy |
19,133
+1,685
| +10% | +$26.1K | 0.02% | 605 |
|
|
2024
Q1 | $278K | Buy |
+17,448
| New | +$278K | 0.02% | 635 |
|
|
2023
Q3 | – | Sell |
-17,941
| Closed | -$241K | – | 696 |
|
|
2023
Q2 | $241K | Sell |
17,941
-1,629
| -8% | -$21.9K | 0.03% | 606 |
|
|
2023
Q1 | $324K | Sell |
19,570
-1,233
| -6% | -$20.4K | 0.04% | 528 |
|
|
2022
Q4 | $387K | Buy |
20,803
+323
| +2% | +$6.01K | 0.04% | 505 |
|
|
2022
Q3 | $263K | Buy |
20,480
+1,579
| +8% | +$20.3K | 0.03% | 597 |
|
|
2022
Q2 | $132K | Buy |
+18,901
| New | +$132K | 0.01% | 691 |
|